MiMedx Group, Inc.
NASDAQ:MDXG · NASDAQ Capital Market
+$0.08 today
Vol 1.79M · Avg 1.55M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
-38.22%
Period High
$7.96
Period Low
$3.09
Latest
$3.67
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Dianthus Therapeutics, Inc.
NASDAQ:DNTH
$3.37B
Taysha Gene Therapies, Inc.
NASDAQ:TSHA
$1.81B
Syndax Pharmaceuticals, Inc.
NASDAQ:SNDX
$1.71B
Innoviva, Inc.
NASDAQ:INVA
$1.66B
Atai Beckley Inc.
NASDAQ:ATAI
$1.48B
Rapport Therapeutics, Inc. Common Stock
NASDAQ:RAPP
$1.36B
Inhibrx Biosciences, Inc.
NASDAQ:INBX
$1.34B
Nektar Therapeutics
NASDAQ:NKTR
$1.17B
CureVac N.V.
CVAC
$1.05B
Sana Biotechnology, Inc.
NASDAQ:SANA
$857.11M
What is the latest MDXG filing?
The latest filing shown is 8-K dated Jun 16, 2026.
How many recent filings does MDXG have?
Intrinsic Alpha currently shows 20 recent filings for MDXG.
Explore More
Continue the stock analysis
Jump to another research area for this company.